Safety of SGLT2 inhibitors, DPP-4 inhibitors, and GLP-1 receptor agonists in US veterans with and without chronic kidney disease: a population-based study

Fritzmann E, Yuen AD, Chang S, Yaqoob M, Kinninger A, Chung J, Vintch JRE, Matusov Y. Clinical features, management, and outcomes of right heart thrombi:[...]

Srivatsa S, Rice N, Pike JR, Smith JA, Ding J, Liu Y, Budoff M, Bey GS. Epigenetic Aging Clocks and Incident Cardiovascular Outcomes: Results From[...]

Shah H, Krishnan S, Narashim A, Korir S, Omondi G, Maxime Ale B, Gitura BM, Kinuthia J, Farquhar C, Hsue PY, Budoff M, Longenecker CT,[...]